Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Inventory Average (2016 - 2025)

Historic Inventory Average for Guided Therapeutics (GTHP) over the last 14 years, with Q3 2025 value amounting to $589000.0.

  • Guided Therapeutics' Inventory Average fell 709.78% to $589000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $589000.0, marking a year-over-year decrease of 709.78%. This contributed to the annual value of $632500.0 for FY2024, which is 720.34% up from last year.
  • Latest data reveals that Guided Therapeutics reported Inventory Average of $589000.0 as of Q3 2025, which was down 709.78% from $614000.0 recorded in Q2 2025.
  • Guided Therapeutics' 5-year Inventory Average high stood at $640000.0 for Q4 2023, and its period low was $566500.0 during Q1 2023.
  • Moreover, its 5-year median value for Inventory Average was $610500.0 (2021), whereas its average is $603894.7.
  • As far as peak fluctuations go, Guided Therapeutics' Inventory Average soared by 107403.85% in 2021, and later crashed by 792.24% in 2022.
  • Quarter analysis of 5 years shows Guided Therapeutics' Inventory Average stood at $580500.0 in 2021, then fell by 1.46% to $572000.0 in 2022, then increased by 11.89% to $640000.0 in 2023, then decreased by 0.86% to $634500.0 in 2024, then dropped by 7.17% to $589000.0 in 2025.
  • Its last three reported values are $589000.0 in Q3 2025, $614000.0 for Q2 2025, and $633000.0 during Q1 2025.